Arcutis Biotherapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Arcutis Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Arcutis Biotherapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Arcutis Biotherapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $6.8k | 2.1k | 3.23 |
| 2023-09-30 | $341k | 64k | 5.31 |
| 2023-06-30 | $1.3M | 140k | 9.53 |
| 2023-03-31 | $977k | 89k | 11.00 |
| 2022-12-31 | $2.9M | 193k | 14.80 |
| 2022-09-30 | $434k | 24k | 18.42 |
| 2022-06-30 | $362k | 17k | 21.64 |
| 2022-03-31 | $1.0M | 54k | 19.26 |
| 2021-12-31 | $1.1M | 55k | 20.74 |
| 2021-09-30 | $603k | 30k | 20.00 |
| 2021-06-30 | $310k | 11k | 27.46 |
| 2021-03-31 | $591k | 20k | 28.91 |
| 2020-09-30 | $18k | 613 | 29.36 |
| 2020-06-30 | $94k | 3.1k | 30.23 |
| 2020-03-31 | $193k | 6.5k | 29.84 |